Topics

Pharmacovigilance 2030: Invited Commentary for the January 2020 "Futures" Edition of Clinical Pharmacology and Therapeutics.

07:00 EST 22nd November 2019 | BioPortfolio

Summary of "Pharmacovigilance 2030: Invited Commentary for the January 2020 "Futures" Edition of Clinical Pharmacology and Therapeutics."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: Clinical pharmacology and therapeutics
ISSN: 1532-6535
Pages:

Links

DeepDyve research library

Clinical Trials [1339 Associated Clinical Trials listed on BioPortfolio]

Healthy Futures Evaluation

This study evaluated the impact of the three-year Healthy Futures program on teen sexual behaviors in three Massachusetts cities.

Adverse Drug Reactions in Pediatrics: Experience of a Regional Pharmacovigilance Center

Aim. — To describe the adverse drug reactions (ADR) and the drugs involved in pediatrics. Methods. — An observational study on all ADR notifications recorded in the French pharmaco-vi...

Stepping Stones and Creating Futures Intervention Pilot

This is a shortened interrupted time series pilot evaluation over a twelve month period to evaluate whether the combined Stepping Stones and Creating Futures intervention can reduce men's ...

Stepping Stones and Creating Futures Intervention Trial

This study evaluates whether the behavioural/structural interventions of Stepping Stones and Creating Futures can reduce the incidence of intimate partner violence in urban informal settle...

Serious Adverse Drug Reaction and Their Preventability

Introduction: Elderly aged over 65 years accounted for around 17.5% of the French general population. Adverse drug reactions (ADR) are common in this population. In elderly subject, preval...

Medical and Biotech [MESH] Definitions

The detection of long and short term side effects of conventional and traditional medicines through research, data mining, monitoring, and evaluation of healthcare information obtained from healthcare providers and patients.

An Act prohibiting a health plan from establishing lifetime limits or annual limits on the dollar value of benefits for any participant or beneficiary after January 1, 2014. It permits a restricted annual limit for plan years beginning prior to January 1, 2014. It provides that a health plan shall not be prevented from placing annual or lifetime per-beneficiary limits on covered benefits. The Act sets up a new competitive health insurance market giving tens of millions of Americans the same choices of insurance that members of Congress will have. It aims to bring greater accountability to health care and to control cost of health insurance premiums.

Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.

Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.

Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.

Quick Search


DeepDyve research library

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...


Searches Linking to this Article